Bone metabolism
| Product name | Osteocalcin (1-43/49) N-MID human | |||||||||||||||||||||
| Cat-Nr. | KT-809 | |||||||||||||||||||||
| Range | 4 - 64 ng/ml | |||||||||||||||||||||
| Sensitivity | 0.3 ng/ml | |||||||||||||||||||||
| Incubation time | 1.5 hours | |||||||||||||||||||||
| Sample volume | 25 μl | |||||||||||||||||||||
| Sample type | serum, plasma | |||||||||||||||||||||
| Sample preparation | Separate serum or plasma within 3 hours after blood collection. Specimens may be stored at 2-8°C for 6 days. For longer storage keep at -20°C. Max. 3 freeze and thaw cycles. Avoid hemolysis. | |||||||||||||||||||||
| Reference values |
| |||||||||||||||||||||
| Species | Human | |||||||||||||||||||||
| Tests | 96 Tests | |||||||||||||||||||||
| Method | ELISA | |||||||||||||||||||||
| Intended use | Osteocalcin can be helpful as a biochemical marker for bone turnover. Increased concentrations are found in patients with different bone diseases that are marked by increased osteoblast activity.• Paget’s disease • Osteomalacia • Bone fibrosis • Renal osteodystrophy • Follow up of osteoporosis treatmentIncreased osteocalcin levels were found in patients with elevated levels of thyroid hormones, growth hormones, vitamin D and parathyroid hormones. | |||||||||||||||||||||
| Product informations | Kit Instructions (PDF 355,1 kB) Cross-reaction all species (PDF 74,6 kB) Bone & Cartilage Metabolism (PDF 1,8 MB) | |||||||||||||||||||||
Back to overview
tecomedical总部位于瑞士的TECOmedical Group在德国，法国和比荷卢三国设有子公司，是医学和兽医诊断，生物安全和环境测试领域体外专业测试系统的领先提供商。此外，我们与意见领袖合作开发或评估新的测试系统，或为制药，CRO和研究组织提供服务。
本网站将在规定时间内给予删除等相关处理。
